Identification | |
---|---|
Name | Sulfoxone |
Accession Number | DB01145 (APRD00704) |
Type | small molecule |
Description | Sulfoxone is a water-soluble sulfone used as an antileprosy drug. It has been used with limited success in the treatment of dermatitis herpetiformis. |
Structure |
|
Categories (*) | |
Molecular Weight | 404.482 |
Groups | approved |
Monoisotopic Weight | 404.017048324 |
Pharmacology | |
Indication | For the treatment of leprosy and dermatitis herpetiformis |
Mechanism of action | Sulfoxone is a competitive inhibitor of bacterial enzyme dihydropteroate synthetase. The normal substrate for the enzyme, para-aminobenzoic acid (PABA) cannot bind as usual. The inhibited reaction is necessary in these organisms for the synthesis of folic acid. |
Absorption | Rapidly absorbed. |
Protein binding | 69% |
Biotransformation | Hepatic. |
Route of elimination | Not Available |
Toxicity | Oral, rat LD50: 7000 mg/kg |
Affected organisms |
|
Interactions | |
Drug Interactions | Not Available |
Food Interactions | Not Available |
Dihydropteroate synthetase | |
---|---|
Name | Dihydropteroate synthetase |
Gene Name | Not Available |
Pharmacological action | yes |
Actions | inhibitor |
References |
|
DTHybrid score | 1.0586 |
Id | Partner name | Gene Name | Score |
---|---|---|---|
620 | Bifunctional dihydrofolate reductase-thymidylate synthase | Not Available | 0.1176 |
3811 | Cytochrome P450 19A1 | CYP19A1 | 0.064 |
4757 | Cytochrome P450 2C9 | CYP2C9 | 0.0616 |
6013 | Cytochrome P450 2E1 | CYP2E1 | 0.0205 |
4924 | Cytochrome P450 2C8 | CYP2C8 | 0.019 |
4512 | Cytochrome P450 3A4 | CYP3A4 | 0.0153 |